LIFECORE BIOMEDICAL, INC. Other Nonoperating Expense
LIFECORE BIOMEDICAL, INC. (LFCR) reported Other Nonoperating Expense of $206.00 thousand for the 3-month period ending 2019-11-24, per its 10-Q filed 2020-01-02.
Discontinued › Income Statement › Other Income
us-gaap:OtherNonoperatingExpense · last filed 2020-01-02
- LIFECORE BIOMEDICAL, INC. other nonoperating expense for the quarter ending 2019-11-24 was $206.00K.
- LIFECORE BIOMEDICAL, INC. other nonoperating expense for the quarter ending 2018-11-25 was $0.00.
| Period end | Other Nonoperating Expense 3 month | Other Nonoperating Expense 6 month |
|---|---|---|
| 2019-11-24 | $206.00K 10-Q · filed 2020-01-02 | $206.00K 10-Q · filed 2020-01-02 |
| 2018-11-25 | $0.00 10-Q · filed 2020-01-02 | $0.00 10-Q · filed 2020-01-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |